PACT: Cloning and characterization of a cellular p53 binding protein that interacts with Rb

Arnold Simons, Cathy Melamed-Bessudo, Roland Wolkowicz, Joseph Sperling, Ruth Sperling, Lea Eisenbach, Varda Rotter*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Abstract

Cellular functions of tumor suppressor proteins can be mediated by protein-protein interactions. Using p53 as a probe to screen an expression library, a cDNA encoding a 250 kDa protein was isolated. Recombinant forms of this protein, designated PACT, bind to wild type p53 while two different mutations abolish this interaction. PACT protein can also interfere with p53 specific DNA binding. PACT contains a serine/arginine (SR) rich region and a C' terminal lysine rich domain. The 250 kDa PACT protein can be precipitated from cell lysates by a method specific for SR proteins. snRNPs can be co-immunoprecipitated from cells with anti-PACT antibodies. These antibodies stain cell nuclei in a speckled pattern reminiscent of the distribution of known splicing factors. Recently, RBQ1, a truncated human homologue of PACT was identified by virtue of Rb binding. We show that RBQ1 is truncated as a result of a possible mutational event. PACT can interact with both cellular Rb and p53.

Original languageEnglish
Pages (from-to)145-155
Number of pages11
JournalOncogene
Volume14
Issue number2
DOIs
StatePublished - 1997

Keywords

  • Rb
  • SR proteins
  • Splicing
  • p53

Fingerprint

Dive into the research topics of 'PACT: Cloning and characterization of a cellular p53 binding protein that interacts with Rb'. Together they form a unique fingerprint.

Cite this